Loading...

Table of Content

    15 November 2020, Volume 15 Issue 11 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    The role of the TrkB-T1 receptor in the neurotrophin-4/5 antagonism of brain-derived neurotrophic factor on corticostriatal synaptic transmission
    Elizabeth Hernández-Echeagaray
    2020, 15 (11):  1973-1976.  doi: 10.4103/1673-5374.282224
    Abstract ( 100 )   PDF (373KB) ( 171 )   Save
    This manuscript reviews the function and fundamental characteristics of the neurotrophins and their receptors to introduce the reader to the differential effects exhibited by the neurotrophins; brain-derived neurotrophic factor and neurotrophin 4/5 when acted together after sequential presentation. The neurotrophin 4/5 exhibits an inhibitory action on the modulatory effect of brain-derived neurotrophic factor in corticostriatal synapses when they are administered sequentially (brain-derived neurotrophic factor to neurotrophin 4/5). This inhibitory effect has not been previously documented and is relevant for these neurotrophins as both of them stimulate the TrkB receptor. The additive effect of these neurotrophins is also discussed and occurs when neurotrophin 4/5 exposure is followed by brain-derived neurotrophic factor in a mouse model of striatal degeneration. Occlusive and additive effects of both neurotrophins are accompanied by changes in the expression of the TrkB receptor isoforms, specifically TrkB-T1 and TrkB-FL, as well as differences in phosphorylation levels of the TrkB receptor. The results of the experiments described raise several questions to inquire about the role that TrkB-T1 receptor plays in striatal physiology, as well as the functional relevance of the interaction of brain-derived neurotrophic factor and neurotrophin 4/5 in the brain and more specifically at the striatal circuits in normal as well as pathological conditions.
    Related Articles | Metrics
    Could non-invasive brain-stimulation prevent neuronal degeneration upon ion channel re-distribution and ion accumulation after demyelination?
    Friederike Pfeiffer, Alia Benali
    2020, 15 (11):  1977-1980.  doi: 10.4103/1673-5374.282234
    Abstract ( 105 )   PDF (945KB) ( 188 )   Save
    Fast and efficient transmission of electrical signals in the nervous system is mediated through myelinated nerve fibers. In neuronal diseases such as multiple sclerosis, the conduction properties of axons are disturbed by the removal of the myelin sheath, leaving nerve cells at a higher risk of degenerating. In some cases, the protective myelin sheath of axons can be rebuilt by remyelination through oligodendroglial cells. In any case, however, changes in the ion channel organization occur and may help to restore impulse conduction after demyelination. On the other hand, changes in ion channel distribution may increase the energy demand of axons, thereby increasing the probability of axonal degeneration. Many attempts have been made or discussed in recent years to increase remyelination of affected axons in demyelinating diseases such as multiple sclerosis. These approaches range from pharmacological treatments that reduce inflammatory processes or block ion channels to the modulation of neuronal activity through electrical cortical stimulation. However, these treatments either affect the entire organism (pharmacological) or exert a very local effect (electrodes). Current results show that neuronal activity is a strong regulator of oligodendroglial development. To bridge the gap between global and very local treatments, non-invasive transcranial magnetic stimulation could be considered. Transcranial magnetic stimulation is externally applied to brain areas and experiments with repetitive transcranial magnetic stimulation show that the neuronal activity can be modulated depending on the stimulation parameters in both humans and animals. In this review, we discuss the possibilities of influencing ion channel distribution and increasing neuronal activity by transcranial magnetic stimulation as well as the effect of this modulation on oligodendroglial cells and their capacity to remyelinate previously demyelinated axons. Although the physiological mechanisms underlying the effects of transcranial magnetic stimulation clearly need further investigations, repetitive transcranial magnetic stimulation may be a promising approach for non-invasive neuronal modulation aiming at enhancing remyelination and thus reducing neurodegeneration.
    Related Articles | Metrics
    The role of exercise in brain DNA damage
    Thais Ceresér Vilela, Vanessa Moraes de Andrade, Zsolt Radak, Ricardo Aurino de Pinho
    2020, 15 (11):  1981-1985.  doi: 10.4103/1673-5374.282237
    Abstract ( 165 )   PDF (395KB) ( 224 )   Save
    Cells are constantly subjected to cytotoxic and genotoxic insults resulting in the accumulation of unrepaired damaged DNA, which leads to neuronal death. In this way, DNA damage has been implicated in the pathogenesis of neurological disorders, cancer, and aging. Lifestyle factors, such as physical exercise, are neuroprotective and increase brain function by improving cognition, learning, and memory, in addition to regulating the cellular redox milieu. Several mechanisms are associated with the effects of exercise in the brain, such as reduced production of oxidants, up-regulation of antioxidant capacity, and a consequent decrease in nuclear DNA damage. Furthermore, physical exercise is a potential strategy for further DNA damage repair. However, the neuroplasticity molecules that respond to different aspects of physical exercise remain unknown. In this review, we discuss the influence of exercise on DNA damage and adjacent mechanisms in the brain. We discuss the results of several studies that focus on the effects of physical exercise on brain DNA damage.
    Related Articles | Metrics
    Combined effect of repetitive transcranial magnetic stimulation and physical exercise on cortical plasticity
    Ya-Wen Yang, Wen-Xiu Pan, Qing Xie
    2020, 15 (11):  1986-1994. 
    Abstract ( 134 )   PDF (208KB) ( 230 )   Save
    Physical exercise can minimize dysfunction and optimize functional motor recovery after stroke by modulating cortical plasticity. However, the limitation of physical exercise is that large amounts of time and effort are necessary to significantly improve motor function, and even then, substantial exercise may not be sufficient to normalize the observed improvements. Thus, interventions that could be used to strengthen physical exercise-induced neuroplasticity may be valuable in treating hemiplegia after stroke. Repetitive transcranial magnetic stimulation seems to be a viable strategy for enhancing such plasticity. As a non-invasive cortical stimulation technique, repetitive transcranial magnetic stimulation is able to induce longterm plastic changes in the motor system. Recently, repetitive transcranial magnetic stimulation was found to optimize the plastic changes caused by motor training, thereby enhancing the long-term effects of physical exercise in stroke patients. Therefore, it is believed that the combination of repetitive transcranial magnetic stimulation and physical exercise may represent a superior method for restoring motor function after stroke.
    Related Articles | Metrics
    Should mast cells be considered therapeutic targets in multiple sclerosis?
    Karen Henriette Pinke, Sofia Fernanda Gonçalves Zorzella-Pezavento, Vanessa Soares Lara, Alexandrina Sartori
    2020, 15 (11):  1995-2007.  doi: 10.4103/1673-5374.282238
    Abstract ( 110 )   PDF (1021KB) ( 143 )   Save
    Mast cells are immune cells of the myeloid lineage that are found throughout the body, including the central nervous system. They perform many functions associated with innate and specific immunity, angiogenesis, and vascular homeostasis. Moreover, they have been implicated in a series of pathologies (e.g., hypersensitivity reactions, tumors, and inflammatory disorders). In this review, we propose that this cell could be a relevant therapeutic target in multiple sclerosis, which is a central nervous system degenerative disease. To support this proposition, we describe the general biological properties of mast cells, their contribution to innate and specific immunity, and the participation of mast cells in the various stages of multiple sclerosis and experimental autoimmune encephalomyelitis development. The final part of this review is dedicated to an overview of the available mast cells immunomodulatory drugs and their activity on multiple sclerosis and experimental autoimmune encephalomyelitis, including our own experience related to the effect of ketotifen fumarate on experimental autoimmune encephalomyelitis evolution.
    Related Articles | Metrics
    Neuroprotection mediated by natural products and their chemical derivatives
    Fei Fei, Ning Su, Xia Li, Zhou Fei
    2020, 15 (11):  2008-2015.  doi: 10.4103/1673-5374.282240
    Abstract ( 164 )   PDF (477KB) ( 257 )   Save
    Neuronal injuries can lead to various diseases such as neurodegenerative diseases, stroke, trauma, ischemia and, more specifically, glaucoma and optic neuritis. The cellular mechanisms that regulate neuronal death include calcium influx and calcium overload, excitatory amino acid release, oxidative stress, inflammation and microglial activation. Much attention has been paid to the effective prevention and treatment of neuroprotective drugs by natural products. This review summarizes the neuroprotective aspects of natural products, extracted from Panax ginseng, Camellia sinensis, soy and some other plants, and some of their chemical derivatives. Their antioxidative and anti-inflammatory action and their inhibition of apoptosis and microglial activation are assessed. This will provide new directions for the development of novel drugs and strategies to treat neurodegenerative diseases.
    Related Articles | Metrics
    Reliable cell purification and determination of cell purity: crucial aspects of olfactory ensheathing cell transplantation for spinal cord repair
    Ronak Reshamwala, Megha Shah, Lucy Belt, Jenny A. K. Ekberg, James A. St John
    2020, 15 (11):  2016-2026.  doi: 10.4103/1673-5374.282218
    Abstract ( 141 )   PDF (1286KB) ( 190 )   Save
    Transplantation of olfactory ensheathing cells, the glia of the primary olfactory nervous system, has been trialed for spinal cord injury repair with promising but variable outcomes in animals and humans. Olfactory ensheathing cells can be harvested either from the lamina propria beneath the neuroepithelium in the nasal cavity, or from the olfactory bulb in the brain. As these areas contain several other cell types, isolating and purifying olfactory ensheathing cells is a critical part of the process. It is largely unknown how contaminating cells such as fibroblasts, other glial cell types and supporting cells affect olfactory ensheathing cell function post-transplantation; these cells may also cause unwanted side-effects. It is also, however, possible that the presence of some of the contaminant cells can improve outcomes. Here, we reviewed the last decade of olfactory ensheathing cell transplantation studies in rodents, with a focus on olfactory ensheathing cell purity. We analyzed how purification methods and resultant cell purity differed between olfactory mucosa- and olfactory bulb-derived cell preparations. We analyzed how the studies reported on olfactory ensheathing cell purity and which criteria were used to define cells as olfactory ensheathing cells. Finally, we analyzed the correlation between cell purity and transplantation outcomes. We found that olfactory bulb-derived olfactory ensheathing cell preparations are typically purer than mucosa-derived preparations. We concluded that there is an association between high olfactory ensheathing cell purity and favourable outcomes, but the lack of olfactory ensheathing cell-specific markers severely hampers the field.
    Related Articles | Metrics
    Regrowth and neuronal protection are key for mammalian hibernation: roles for metabolic suppression
    Samantha M. Logan, Kenneth B. Storey
    2020, 15 (11):  2027-2028.  doi: 10.4103/1673-5374.282242
    Abstract ( 177 )   PDF (371KB) ( 893 )   Save
    Thought experiment: you’re starving, huddled in the fetal position in a hole in the ground, with no sense of the world around you, except that you are really, really cold. In fact, your internal temperature can go as low as –2.9°C, which is as dangerous as it sounds, and somehow, you are not freaking out. Actually, your heart rate is only two beats per minute, and you are breathing just a few shallow breaths every half hour or so. You’re not dead, so what are you? You’re hibernating. Hibernation is a form of torpor used by capable species to defend against the stressors of the winter months such as low ambient temperatures and low food availability. It is characterized by substantial decreases in metabolic rate, breathing and heart rates, and organ perfusion. For this reason, hibernator brains are unique and a little unusual, at least, unusual enough to tolerate and survive these inhospitable conditions. Despite brains being especially sensitive to changes in oxygen/nutrient availability and temperature, hibernators can withstand decreases in brain perfusion of ~90% compared to euthermic levels and changes in body temperatures (Tb) from ~37°C to as low as –2.9°C (Schwartz et al., 2013; Tessier et al., 2019). Yet, hibernators arise from their final torpor-arousal cycle in the spring with no signs of brain injury, almost immediately remembering how to forage for food and find summertime mates. How do hibernators prevent and reverse brain damage? We will describe the role of temperature and torpor in the preservation of hibernator brain integrity with a focus on the molecular aspects of dendritic reorganization.
    Related Articles | Metrics
    Exercise, microglia, and beyond – workout to communicate with microglia
    Megumi Andoh, Ryuta Koyama
    2020, 15 (11):  2029-2030.  doi: 10.4103/1673-5374.282241
    Abstract ( 111 )   PDF (367KB) ( 162 )   Save
    Microglia are brain-resident immune cells that use their ramified processes to survey the brain parenchyma. They maintain brain ho- meostasis by mediating immune responses through cytokine release, phagocytosing pathogens and protein aggregation (Salter et al., 2017). Furthermore, in both healthy and disease states, microglia interacting with neurons regulate synaptic formation, elimination and plasticity (Salter et al., 2017). It is thought that these functions may be altered by environmental stimuli such as lifestyle, stress, infection and air pollu- tion, the effects of which may result in brain dysfunction and the de- velopment of neurodegenerative diseases (Branchi et al., 2014; Hanam- sagar et al., 2017).
    Related Articles | Metrics
    Tunneling nanotubes and actin cytoskeleton dynamics in glaucoma
    Kate E. Keller
    2020, 15 (11):  2031-2032.  doi: 10.4103/1673-5374.282254
    Abstract ( 97 )   PDF (1703KB) ( 211 )   Save
    Glaucoma is an optic neuropathy, with pathophysiological changes affecting anterior and posterior tissues of the eye. The trabecular meshwork (TM) in the anterior segment regulates intraocular pressure (IOP), while photoreceptors in the posterior retina convert light into signals that retinal ganglion cells (RGC) transmit to the brain. The TM is a small, fenestrated tissue located in the anterior chamber angle, between the iris and cornea (Figure 1A1). In humans, the majority of aqueous humor fluid drains through the TM into Schlemm’s canal. If the outflow channels become blocked, as in glaucoma, IOP starts to increase, pushing the lens and vitreous back onto the optic disk. Pressure-induced damage to the optic nerve head causes a pro- gressive loss of RGCs and their axons, which leads to irreversible blindness. Surgical or pharmacological management of IOP prevents RGC damage in glau- coma patients. Standard pharmacological therapies either reduce production of aqueous humor fluid, or increase aqueous drainage via the TM or the uveoscleral outflow pathways. Recently, a new class of glaucoma therapies targeting the actin cytoskeleton were approved by the Food and Drug Administration. These are known as the Rho kinase inhibitors, and they act on the Rho/Rho-associated protein kinase signaling pathway to disassemble actin stress fibers in TM and Schlemm’s canal cells (Rao et al., 2017; Lin et al., 2018). While the molecular details are only partially understood, perturbing the actomyosin system can alter cell shape, volume, contractility, and adhesion of cells to extracellular matrix (Tian et al., 2009), which in turn allows greater aqueous outflow and a reduction in IOP. In addition to forming stress fibers, filamentous actin assembles into actin bundles, which are a major component of filopodia, long finger-like projections that emanate from the cell surface, as well as the related cellular protrusions known as tunneling nanotubes (TNTs) .
    Related Articles | Metrics
    Synaptic receptors for low pH in extracellular space: metabotropic receptors are an underestimated factor in stroke
    Sergei V. Fedorovich, Tatsiana G. Dubouskaya, Tatsiana V. Waseem
    2020, 15 (11):  2033-2034.  doi: 10.4103/1673-5374.282249
    Abstract ( 87 )   PDF (228KB) ( 204 )   Save
    In the brain, extracellular pH could decrease in certain diseases. Acidification, however, is especially attributable for stroke. Lactate accumulation in the absence of anaerobic respiration is the main, but not the only, reason for lowering pH in this condition (Wemmie et al., 2013). In addition, local pH changes in the synaptic cleft may result from the release of acidic content of synaptic vesicles (Sinning and Hubner, 2013). Acidification is able to damage or even kill a neuron. The damaging effect of low pH can be mediated by a direct effect of protons on enzymes or transport systems. It can also, however, be mediated by specific receptors (Wemmie et al., 2013; Levin and Buck, 2015). The most well studied class of pH receptors is ionotropic acid-sensing ion channels (ASIC). These are ion channels which are permeable for sodium and calcium. They open in response to extracellular acidification. Activation of these receptors could lead to neuronal death (Wemmie et al., 2013). ASIC-induced neuronal death is appeared to be involved in stroke-induced brain damage. This suggestion is supported by the fact that amiloride, which inhibits ASIC, has a neuroprotective effect in stroke (Xiong et al., 2004). Amiloride is able to reduce currents through ASIC types, however, the exact structural basis for this phenomenon is still not very clear (Wemmie et al., 2013). Generally, the majority of hormones and neurotransmitters exert their action via two main types of receptors. These are ionotropic and metabotropic receptors. The function of ionotropic channels is mediated by ion channel opening and ion fluxes through plasma membranes. The function of metabotropic receptors is mediated by G-proteins and enzymatic reactions. In this case, a cellular response will be slower and it will be rather fine tuning than the “all-ornothing” effect. This seems to be the key difference between ionotropic and metabotropic receptors. Based on the knowledge in this field, the existence of both metabotropic and ionotropic receptors, which could respond to changes in extracellular pH, is possible. By now, proteins with this function have been found on plasma membrane of eukaryotic cells (Levin and Buck, 2015). The role of metabotropic receptors for low pH in regulation of activity of central nervous system cells, however, is still not very understood. Recently, we have shown that the activation of metabotropic receptor for low pH on plasma membrane of isolated neuronal presynaptic endings, most likely ovarian cancer G-protein- coupled receptor 1 (OGR1), leads to mitochondria depolarization (Dubouskaya et al., 2018).
    Related Articles | Metrics
    Regulation of β2-adrenoceptors in brain glia: implications for neuroinflammatory and degenerative disorders
    Karen M. Ryan, Andrew Harkin
    2020, 15 (11):  2035-2036.  doi: 10.4103/1673-5374.282255
    Abstract ( 87 )   PDF (550KB) ( 139 )   Save
    Within the central nervous system (CNS), the primary source of the catecholamine neurotransmitter noradrenaline is the locus coeruleus (LC) in the pontine tegmentum, with LC neurons projecting to almost all regions of the brain and spinal cord. Following its release from LC neurons, noradrenaline has wide ranging effects. For example, noradrenaline is the endogenous agonist for G-coupled α- and β-adrenoceptors that are expressed on many cell types, including neurons and glia, in both the peripheral nervous system and CNS. It is via these receptors that noradrenaline exerts its anti-inflammatory and neurotrophic effects in the brain. Noradrenaline additionally has adrenoceptor-independent neuroprotective actions, and as such plays a role in free radical scavenging and reducing oxidative stress (Feinstein et al., 2016).
    Related Articles | Metrics
    Nogo-A and the regulation of neurotransmitter receptors
    Bor Luen Tang
    2020, 15 (11):  2037-2038.  doi: 10.4103/1673-5374.282250
    Abstract ( 71 )   PDF (272KB) ( 922 )   Save
    Nogo-A is known to restrict plasticity in the adult central nervous system, and signalling through its cognate receptors modulates synaptic spine architecture and excitatory glutamate transmission via restricting synaptic glutamate receptor levels and their delivery to the post-synaptic compartments. A recent report now indicates that Nogo-A, signaling through Sphingosine-1-Phosphate Receptor 2, also strengthens inhibitory gamma amino acid butyric acid (GABA)ergic transmission by limiting the diffusion dynamics of GABAA receptors. This reciprocal modulation of excitatory and inhibitory signaling via neurotransmitter receptor dynamics by Nogo-A likely plays important pathophysiological roles in synaptic plasticity during development and injury.
    Related Articles | Metrics
    Perspectives on mild cognitive impairment as a precursor of Alzheimer’s disease
    Rosamaria Fiorini, Simona Luzzi, Arianna Vignini
    2020, 15 (11):  2039-2040.  doi: 10.4103/1673-5374.282256
    Abstract ( 112 )   PDF (419KB) ( 178 )   Save
    The aging population is growing rapidly all over the world due to the increase in average life. One of the major challenges associated with an aging population is dementia. Worldwide, it is estimated that by 2050 the number of people with dementia could triple, and dementia not only dramatically changes the lives of those who suffer from it, but it also results in a serious burden for health care systems and caregivers.
    Related Articles | Metrics
    How can proton pump inhibitors damage central and peripheral nervous systems?
    Tigran Makunts, Ruben Abagyan
    2020, 15 (11):  2041-2042.  doi: 10.4103/1673-5374.282252
    Abstract ( 181 )   PDF (474KB) ( 342 )   Save
    Proton-pump inhibitors (PPIs) are first line therapy for most gastroesophageal acid-related disorders. They include reflux disorders, Helicobacter pylori infections, Zollinger-Ellison syndrome, and gastroesophageal malignancies. In clinical practice, PPIs have largely replaced histamine-2 receptor antagonists (H2RAs) due to their superior efficacy and are currently widely prescribed and sold worldwide. (Kantor et al., 2015). Since the PPIs are, in addition, freely available without prescription in the United States, there has been a growing concern over proton-pump inhibitor prolonged use and serious side effects such as Alzheimer’s disease (AD) type dementia. A few large scale studies have shown an increased risk of the AD type and non-AD type dementia with PPI use, while others have questioned this association (Novotny et al., 2018; Khan et al., 2020). Aside from the memory impairment related adverse events, PPI use has been reported to be associated with neuropathies in a few case reports (Rajabally and Jacob, 2005). We investigated these associations by analyzing of postmarketing adverse event (AE) reports for patients on PPI (n = 42,537) and H2RA (n = 8309) monotherapy in United States Food and Drug Administration Adverse Event Reporting System datasets. Initially, every report where a PPI or an H2RA was used were selected into the antacid cohort. The data set was further split into PPI and H2RA arms. Reports where a PPI or an H2RA was the only medication used were selected into their respective cohorts, excluding all concurrent medications and comorbidities. Adverse event report rates were analyzed via odds ratio analysis and 95% confidence intervals. We found a significantly increased risk of memory impairment, including both AD- and non- AD type dementia conditions, in PPI-treated patients (odds ratio 3.28, 95% confidence interval [2.31, 4.67]) (Makunts et al., 2019a). Additionally, we found that virtually every neurologic disease state related adverse event had a significantly higher reporting frequency and increased risk in the PPI monotherapy cohort: hearing impairment (11.64 [5.20, 26.11]), visual impairment (1.85 [1.44, 2.37]), neurological/ neuropathic impairment (8.68 [3.86, 19.49], seizure related adverse events (1.54 [1.06, 2.24]), and migraines (2.19 [1.29, 3.72]) (Makunts et al., 2019a). To the best of our knowledge this was the first large scale study to confirm the previously observed associations of PPI use with a wide range of neurological AEs involving both central and peripheral nervous systems (CNS and PNS).
    Related Articles | Metrics
    Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
    Javier Riancho, Sara Arozamena, Adolfo López de Munaín
    2020, 15 (11):  2043-2044.  doi: 10.4103/1673-5374.282257
    Abstract ( 89 )   PDF (722KB) ( 185 )   Save
    Among neurodegenerative diseases, amyotrophic lateral scle- rosis (ALS) is the most frequent one involving motor neurons (MNs). ALS incidence varies throughout the world ranging from 0.7 to 4 cases per 100,000 habitants and year (Riancho et al., 2016). This disease, which currently lacks an effective ther- apy, is characterized by a variable combination of upper and lower MN degeneration, leading to progressive muscle wasting which usually results in a terminal respiratory failure within 3 years after symptom onset (Zufiria et al., 2016). A small propor- tion of ALS cases show familial aggregation. These are related to mutations in specific causative genes (Cr9ORF72, TARDBP, FUS, SOD1 and others) which directly determine disease onset in carriers. By contrast, more than 90 percent of cases are con- sidered to be sporadic, in which generally unknown environ- mental and internal factors interact with genetic predisposing factors finally leading to disease (Riancho et al., 2018). From a histopathological point of view, ALS is characterized by MN damage and loss. MNs from ALS sporadic and most of familial patients exhibit prominent transactive response DNA-binding protein 43 (TDP-43) cytoplasmic aggregates which are con- sidered as the “pathological hallmark” of the disease, except- ing those related to SOD1 and FUS mutations (Zufiria et al., 2016). TDP-43 is a DNA/RNA binding protein encoded by the TARDBP gene that controls the expression of many different genes.
    Related Articles | Metrics
    Using single cell transcriptomics to study the complexity of human retina
    Daniel Urrutia-Cabrera, Raymond Ching-Bong Wong
    2020, 15 (11):  2045-2046.  doi: 10.4103/1673-5374.282253
    Abstract ( 120 )   PDF (800KB) ( 262 )   Save
    The human retina is a specialized multilayered structure composed of numerous cell types. The process of vision relies on a robust network integrated by rod photoreceptors, cone photoreceptors, bipolar cells, horizontal cells, amacrine cells and retinal ganglion cells, which detect, process and relay the visual information to the brain. Additionally, structural and metabolic support is provided by Müller glia, retinal as- trocytes and microglia. Over 200 genes have been implicated in inher- ited retinal diseases (RetNet: https://sph.uth.edu/retnet/). However, in many cases, the retinal cell types that express these disease-associated genes remain to be identified. The complexity of the human retina rep- resents a major challenge for the molecular profiling of all retinal cell types. Many previous studies utilised bulk RNA-seq to profile the whole human adult retina, which only analysed the averaged gene expression levels across all retinal cell types. As such, knowledge of the transcrip- tome profile in specific cell types within the retina would help us to unravel the heterogeneity of retinal cells, advance understanding of the pathogenesis of inherited retinal diseases, and to develop gene therapies that could improve treatment options.
    Related Articles | Metrics
    Paired associated magnetic stimulation promotes neural repair in the rat middle cerebral artery occlusion model of stroke
    Bei-Yao Gao, Cheng-Cheng Sun, Guo-Hua Xia, Shao-Ting Zhou, Ye Zhang, Ye-Ran Mao, Pei-Le Liu, Ya Zheng, Dan Zhao, Xu-Tong Li , Janie Xu, Dong-Sheng Xu, Yu-Long Bai
    2020, 15 (11):  2047-2056.  doi: 10.4103/1673-5374.282266
    Abstract ( 155 )   PDF (1508KB) ( 239 )   Save
    Paired associative stimulation has been used in stroke patients as an innovative recovery treatment. However, the mechanisms underlying the therapeutic effectiveness of paired associative stimulation on neurological function remain unclear. In this study, rats were randomly divided into middle cerebral occlusion model (MCAO) and paired associated magnetic stimulation (PAMS) groups. The MCAO rat model was produced by middle cerebral artery embolization. The PAMS group received PAMS on days 3 to 20 post MCAO. The MCAO group received sham stimulation, three times every week. Within 18 days after ischemia, rats were subjected to behavioral experiments—the foot-fault test, the balance beam walking test, and the ladder walking test. Balance ability was improved on days 15 and 17, and the foot- fault rate was less in their affected limb on day 15 in the PAMS group compared with the MCAO group. Western blot assay showed that the expression levels of brain derived neurotrophic factor, glutamate receptor 2/3, postsynaptic density protein 95 and synapsin-1 were significantly increased in the PAMS group compared with the MCAO group in the ipsilateral sensorimotor cortex on day 21. Resting-state functional magnetic resonance imaging revealed that regional brain activities in the sensorimotor cortex were increased in the ipsilateral hemisphere, but decreased in the contralateral hemisphere on day 20. By finite element simulation, the electric field distribution showed a higher intensity, of approximately 0.4 A/m 2 , in the ischemic cortex compared with the contralateral cortex in the template. Together, our findings show that PAMS upregulates neuroplasticity-related proteins, increases regional brain activity, and promotes functional recovery in the affected sensorimotor cortex in the rat MCAO model. The experiments were approved by the Institutional Animal Care and Use Committee of Fudan University, China (approval No. 201802173S) on March 3, 2018.
    Related Articles | Metrics
    Cerebral dopamine neurotrophic factor promotes the proliferation and differentiation of neural stem cells in hypoxic environments
    Chao-Qun Lin, Lu-Kui Chen
    2020, 15 (11):  2057-2062.  doi: 10.4103/1673-5374.282262
    Abstract ( 165 )   PDF (1200KB) ( 154 )   Save
    Previous research found that cerebral dopamine neurotrophic factor (CDNF) has a protective effect on brain dopaminergic neurons, and CDNF is regarded as a promising therapeutic agent for neurodegenerative diseases. However, the effects of CDNF on the proliferation, dif- ferentiation, and apoptosis of neural stem cells (NSCs), which are very sensitive to hypoxic environments, remain unknown. In this study, NSCs were extracted from the hippocampi of fetal rats and cultured with different concentrations of CDNF. The results showed that 200 nM CDNF was the optimal concentration for significantly increasing the viability of NSCs under non-hypoxic environmental conditions. Then, the cells were cultured with 200 nM CDNF under the hypoxic conditions of 90% N 2 , 5% CO 2 , and 5% air for 6 hours. The results showed that CDNF significantly improved the viability of hypoxic NSCs and reduced apoptosis among hypoxic NSCs. The detection of markers showed that CDNF increased the differentiation of hypoxic NSCs into neurons and astrocytes. CDNF also reduced the expression level of Lin28 protein and increased the expression of Let-7 mRNA in NSCs, under hypoxic conditions. In conclusion, we determined that CDNF was able to reverse the adverse proliferation, differentiation, and apoptosis effects that normally affect NSCs in a hypoxic environ- ment. Furthermore, the Lin28/Let-7 pathway may be involved in this regulated function of CDNF. The present study was approved by the Laboratory Animal Centre of Southeast University, China (approval No. 20180924006) on September 24, 2018.
    Related Articles | Metrics
    Injury of the dentatorubrothalamic tract in patients with post-traumatic tremor following mild traumatic brain injury: a case-control study
    Sung Ho Jang, Han Do Lee
    2020, 15 (11):  2063-2066.  doi: 10.4103/1673-5374.282259
    Abstract ( 106 )   PDF (586KB) ( 391 )   Save
    Post-traumatic movement disorder is one of the sequelae of traumatic brain injury. The dentatorubrotha- lamic tract (DRTT) is reported to be involved in the control of movement. Therefore, injury of the DRTT can be accompanied by abnormal movements, including ataxia, tremor, or dystonia. We investigated DRTT injuries in 27 patients who showed post-traumatic tremor in at least one of four extremities following mild traumatic brain injury. We classified DRTT injuries based on diffusion tensor tractography parameters and configuration: type A: the DRTT showed narrowing, type B: the DRTT showed partial tearing, and type C: the DRTT showed discontinuation. Fractional anisotropy and fiber number of the DRTT were significantly decreased in patients compared with the healthy controls. Based on our DRTT injury classification, among the 54 hemispheres of the 27 patients, type A injury occurred in 22 hemispheres (40.7%) of 17 patients, type B injury was present in 15 hemispheres (27.7%) of 10 patients, and type C injury was observed in 8 hemi- spheres (14.8%) of 6 patients. Our results suggest that diffusion tensor tractography-based evaluation of the DRTT would be useful when determining cause of post-traumatic tremor in patients with mild traumatic brain injury. The study protocol was approved by the Institutional Review Board of Yeungnam University Hospital (YUMC-2018-09-007) on September 5, 2018.
    Related Articles | Metrics
    Aquatic exercise program-modulated oxidative stress markers in patients with Parkinson’s disease
    Caroline Dani, Isabel Teixeira Proença, Jessica Marinho, Pâmela Peccin, Ivy Reichert Vital da Silva, Simone Nique, Vera Striebel, Daniela Pochmann, Viviane Rostirola Elsner
    2020, 15 (11):  2067-2072.  doi: 10.4103/1673-5374.276337
    Abstract ( 139 )   PDF (597KB) ( 173 )   Save
    Parkinson’s disease is a neurodegenerative disease. Oxidative stress, i.e., the imbalance between the gen- eration of reactive oxygen species and the antioxidant defense capacity of the body, plays an important role in the pathogenesis of this disease. Physical exercise can regulate oxidative stress. The purpose of this study was to analyze the short- and long-term effects of an aquatic exercise program on oxidative stress levels in patients with Parkinson’s disease. The aquatic exercise program was carried out during 1 month with two sessions per week (1 hour/session). Blood samples were collected at four different time points: pre-intervention, immediately, 48 hours, and 30 days after the first session of aquatic exercise program. Our results revealed that water-based programs modulated antioxidant enzyme activity, increased superoxide dismutase activity, reduced catalase activity, and increased the ratio of superoxide dismutase activity to catalase activity in patients with Parkinson’s disease. Compared with pre-intervention and 48 hours after the first session of aquatic exercise program, superoxide dismutase activity was higher and catalase activity was lower immediately and 30 days after the first session. Our results demonstrated that aquatic exercise program could modulate oxidative stress, mainly by the effect of antioxidant enzyme activity. These results could better help understand the target of oxidative stress in Parkinson’s disease. This study was approved by the Ethics Committee of Centro Universitário Metodista IPA (approval No. 1.373.911) on August 9, 2019 and registered with REBEC (registration number: RBR-6NJ4MK).
    Related Articles | Metrics
    Acute effects of human protein S administration after traumatic brain injury in mice
    Xiaowei Wang, Jing Tong, Xiaodi Han, Xiaoming Qi, Jun Zhang, Erxi Wu, Jason H. Huang
    2020, 15 (11):  2073-2081.  doi: 10.4103/1673-5374.282258
    Abstract ( 109 )   PDF (4781KB) ( 793 )   Save
    Despite years of effort, no effective acute phase treatment has been discovered for traumatic brain injury. One impediment to successful drug development is entangled secondary injury pathways. Here we show that protein S, a natural multifunctional protein that regulates coagulation, inflammation, and apoptosis, is able to reduce the extent of multiple secondary injuries in traumatic brain injury, and therefore improve prognosis. Mice subjected to controlled cortical impact were treated acutely (10–15 minutes post-injury) with a single dose of either protein S (1 mg/kg) or vehicle phosphate buffered saline via intravenous in- jection. At 24 hours post-injury, compared to the non-treated group, the protein S treated group showed substantial improvement of edema and fine motor coordination, as well as mitigation of progressive tissue loss. Immunohistochemistry and western blot targeting caspase-3, B-cell lymphoma 2 (Bcl-2) along with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay revealed that apoptosis was suppressed in treated animals. Immunohistochemistry targeting CD11b showed limited leukocyte infil- tration in the protein S-treated group. Moreover, protein S treatment increased the ipsilesional expression of aquaporin-4, which may be the underlying mechanism of its function in reducing edema. These results indicate that immediate intravenous protein S treatment after controlled cortical impact is beneficial to traumatic brain injury prognosis. Animal Use Protocols (AUPs) were approved by the University Commit- tee on Animal Resources (UCAR) of University of Rochester Medical Center (approval No. UCAR-2008- 102R) on November 12, 2013.
    Related Articles | Metrics
    Effects of mild intrauterine hypoperfusion in the second trimester on memory and learning function in rat offspring
    Shao-Wei Yin, Yuan Wang, Yi-Lin Meng, Cai-Xia Liu
    2020, 15 (11):  2082-2088.  doi: 10.4103/1673-5374.282268
    Abstract ( 107 )   PDF (2600KB) ( 231 )   Save
    Mild intrauterine hypoperfusion (MIUH) is a serious pathological event that affects the growth and development of fetuses and offspring. MIUH can lead to growth restriction, low birth weight, neurodevelopmental disorders, and other adverse clinical outcomes. To study the effects of MIUH on learning and memory function in offspring, a model of MIUH was established by placing a coil (length 2.5 mm, diam- eter 0.24 mm) on the uterine artery and ovarian uterine artery of Sprague-Dawley rats in the second trimester of pregnancy (day 17). Next, 120 mg/kg lithium chloride (the MIUH + Li group) or normal saline (the MIUH group) was injected intraperitoneally into these rats. In addition, 120 mg/kg lithium chloride (the Li group) or normal saline (the SHAM group) was injected intraperitoneally into pregnant rats without coil placement. The Morris water maze was used to detect changes in learning and memory ability in the offspring at 4 weeks after birth. In the MIUH group, the escape latency and journey length before reaching the platform were both increased, and the number of times that the platform was crossed and the activity time in the target quadrant within 90 seconds were both decreased compared with the SHAM group. Immunofluorescence double staining and western blot assays demonstrated that hippocampal nestin and Ki67 (both cell-proliferation-related proteins) expression was significantly downregulated in the MIUH group compared with the SHAM group. Fur- thermore, western blot assays were conducted to investigate changes in related signaling pathway proteins in the brains of offspring rats, and revealed that glycogen synthase kinase 3β (GSK3β) expression was upregulated and β-catenin expression was downregulated in the MIUH group compared with the SHAM group. In addition, compared with the MIUH group, the expression levels of p-GSK3β and β-cat- enin were upregulated in the MIUH + Li group. These results suggest that MIUH may affect learning and memory function in rat offspring by regulating the GSK3β signaling pathway. The experimental procedures were approved by Animal Ethics Committee of Shengjing Hospi- tal of China Medical University (approval No. 2018PS07K) in June 2018.
    Related Articles | Metrics
    Research hotspots and effectiveness of repetitive transcranial magnetic stimulation in stroke rehabilitation
    Ai-Hua Xu, Yong-Xin Sun
    2020, 15 (11):  2089-2097.  doi: 10.4103/1673-5374.282269
    Abstract ( 213 )   PDF (3134KB) ( 519 )   Save
    Repetitive transcranial magnetic stimulation, as a relatively new type of rehabilitation treatment, is a pain- less and non-invasive method for altering brain excitability. Repetitive transcranial magnetic stimulation has been widely used in the neurorehabilitation of stroke patients. Here, we used CiteSpace software to visually analyze 315 studies concerning repetitive transcranial magnetic stimulation for stroke rehabili- tation from 1999 to 2019, indexed by Web of Science, to clarify the research hotspots in different periods and characterize the gradual process of discovery in this field. We found that four main points were gen- erally accepted: (1) repetitive transcranial magnetic stimulation has a positive effect on motor function recovery in patients with subcortical stroke; (2) it may be more advantageous for stroke patients to receive low-frequency repetitive transcranial magnetic stimulation in the unaffected hemispheres than to receive high-frequency repetitive transcranial magnetic stimulation in affected hemisphere; (3) low-frequency repetitive transcranial magnetic stimulation has become a potential therapeutic tool for patients with non-fluent aphasia after chronic stroke for neurological rehabilitation and language recovery; and (4) there are some limitations to these classic clinical studies, such as small sample size and low test efficiency. Our assessment indicates that prospective, multi-center, large-sample, randomized controlled clinical trials are still needed to further verify the effectiveness of various repetitive transcranial magnetic stimulation pro- grams for the rehabilitation of stroke patients.
    Related Articles | Metrics
    Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice
    Chia George Hsu, M A Hassan Talukder, Li Yue, Loel C. Turpin, Mark Noble, John C. Elfar
    2020, 15 (11):  2098-2107.  doi: 10.4103/1673-5374.280319
    Abstract ( 139 )   PDF (2628KB) ( 259 )   Save
    4-Aminopyridine (4-AP), an FDA-approved drug for the symptomatic treatment of multiple sclerosis, is used to improve neuromuscular function in patients with diverse demyelinating disorders. We recently demonstrated that local, transdermal or injectable forms of 4-AP improve myelination, nerve conduction velocity, muscle atrophy, and motor function after traumatic peripheral nerve injury in mice. While oral 4-AP is most commonly used in the clinic, it is unknown whether human equivalent oral doses of 4-AP have effects on traumatic pe- ripheral nerve injury differentiation, myelination, muscle atrophy, functional recovery, and post-injury inflammatory processes in animals. Mice with sciatic nerve crush or denervation injury received oral or intraperitoneal 4-AP (10 µg) or vehicle alone and were examined for pharmacokinetics, motor function, muscle mass, intrinsic muscle force, nerve morphological and gene expression profiles. 4-AP showed linear pharmacokinetics and the maximum plasma 4-AP concentrations were proportional to 4-AP dose. Acute single dose of oral 4-AP administration induced a rapid transient improvement in motor function that was different in traumatic peripheral nerve injury with or without nerve continuity, chronic daily oral 4-AP treatment significantly enhanced post crush injury motor function recovery and this effect was associated with improved myelination, muscle mass, and ex vivo muscle force. Polymerase chain reaction array analysis with crushed nerve revealed significant alterations in gene involved in axonal inflammation and regeneration. These findings provide convincing evidence that regardless of the route of administration, 4-AP can acutely differentiate traumatic peripheral nerve injury with or without nerve con- tinuity and can enhance in vivo functional recovery with better preservation of myelin sheaths, muscle mass, and muscle force. The animal experiments were approved by the University Committee on Animal Research (UCAR) at the University of Rochester (UCAR-2009-019) on March 31, 2017.
    Related Articles | Metrics
    Intraoperative single administration of neutrophil peptide 1 accelerates the early functional recovery of peripheral nerves after crush injury
    Yu-Song Yuan, Su-Ping Niu, Fei Yu, Ya-Jun Zhang, Na Han, Hao Lu, Xiao-Feng Yin, Hai-Lin Xu, Yu-Hui Kou
    2020, 15 (11):  2108-2115.  doi: 10.4103/1673-5374.282270
    Abstract ( 159 )   PDF (3928KB) ( 211 )   Save
    Neutrophil peptide 1 belongs to a family of peptides involved in innate immunity. Continuous intramuscular injection of neutrophil pep- tide 1 can promote the regeneration of peripheral nerves, but clinical application in this manner is not convenient. To this end, the effects of a single intraoperative administration of neutrophil peptide 1 on peripheral nerve regeneration were experimentally observed. A rat model of sciatic nerve crush injury was established using the clamp method. After model establishment, a normal saline group and a neu- trophil peptide 1 group were injected with a single dose of normal saline or 10 µg/mL neutrophil peptide 1, respectively. A sham group, without sciatic nerve crush was also prepared as a control. Sciatic nerve function tests, neuroelectrophysiological tests, and hematoxy- lin-eosin staining showed that the nerve conduction velocity, sciatic functional index, and tibialis anterior muscle fiber cross-sectional area were better in the neutrophil peptide 1 group than in the normal saline group at 4 weeks after surgery. At 4 and 8 weeks after surgery, there were no differences in the wet weight of the tibialis anterior muscle between the neutrophil peptide 1 and saline groups. Histological stain- ing of the sciatic nerve showed no significant differences in the number of myelinated nerve fibers or the axon cross-sectional area between the neutrophil peptide 1 and normal saline groups. The above data confirmed that a single dose of neutrophil peptide 1 during surgery can promote the recovery of neurological function 4 weeks after sciatic nerve injury. All the experiments were approved by the Medical Ethics Committee of Peking University People’s Hospital, China (approval No. 2015-50) on December 9, 2015.
    Related Articles | Metrics
    Sequencing analysis of matrix metalloproteinase 7-induced genetic changes in Schwann cells
    Pan-Jian Lu, Gang Wang, Xiao-Dong Cai, Ping Zhang, Hong-Kui Wang
    2020, 15 (11):  2116-2122.  doi: 10.4103/1673-5374.282263
    Abstract ( 108 )   PDF (1758KB) ( 307 )   Save
    Previous research revealed the positive activity of matrix metalloproteinase 7 (MMP7) on migration and myelin regeneration of Schwa nn cells (SCs). However, understanding of the molecular changes and biological activities induced by increased amounts of MMP7 in SCs remains limited. To better understand the underlying molecular events, primary SCs were isolated from the sciatic nerve stump of new- born rats and cultured with 10 nM human MMP7 for 24 hours. The results of genetic testing were analyzed at a relatively relaxed threshold value (fold change ≥ 1.5 and P-value < 0.05). Upon MMP7 exposure, 149 genes were found to be upregulated in SCs, whereas 133 genes were downregulated. Gene Ontology analysis suggested that many differentially expressed molecules were related to cellular processes, sin- gle-organism processes, and metabolic processes. Kyoto Enrichment of Genes and Genomes pathway analysis further indicated the critical involvement of cell signaling and metabolism in MMP7-induced molecular regulation of SCs. Results of Ingenuity Pathway Analysis (IPA) also revealed that MMP7 regulates biological processes, molecular functions, cellular components, diseases and functions, biosynthesis, material metabolism, cell movement, and axon guidance. The outcomes of further analysis will deepen our comprehension of MMP7-in- duced biological changes in SCs. This study was approved by the Laboratory Animal Ethics Committee of Nantong University, China (approval No. 20190225-004) on February 27, 2019.
    Related Articles | Metrics
    MicroRNA regulatory pattern in spinal cord ischemia- reperfusion injury
    Zhi-Gang Liu, Yin Li, Jian-Hang Jiao, Hao Long, Zhuo-Yuan Xin, Xiao-Yu Yang
    2020, 15 (11):  2123-2130.  doi: 10.4103/1673-5374.280323
    Abstract ( 136 )   PDF (2231KB) ( 291 )   Save
    After spinal cord injury, dysregulated miRNAs appear and can participate in inflammatory responses, as well as the inhibition of apoptosis and axon regeneration through multiple pathways. However, the functions of miRNAs in spinal cord ischemia-reperfusion injury pro- gression remain unclear. miRCURY LNATM Arrays were used to analyze miRNA expression profiles of rats after 90 minutes of ischemia followed by reperfusion for 24 and 48 hours. Furthermore, subsequent construction of aberrantly expressed miRNA regulatory patterns involved cell survival, proliferation, and apoptosis. Remarkably, the mitogen-activated protein kinase (MAPK) signaling pathway was the most significantly enriched pathway among 24- and 48-hour groups. Bioinformatics analysis and quantitative reverse transcription poly- merase chain reaction confirmed the persistent overexpression of miR-22-3p in both groups. These results suggest that the aberrant miRNA regulatory network is possibly regulated MAPK signaling and continuously affects the physiological and biochemical status of cells, thus participating in the regulation of spinal cord ischemia-reperfusion injury. As such, miR-22-3p may play sustained regulatory roles in spinal cord ischemia-reperfusion injury. All experimental procedures were approved by the Animal Ethics Committee of Jilin University, China [approval No. 2020 (Research) 01].
    Related Articles | Metrics
    Amyloid-beta peptide neurotoxicity in human neuronal cells is associated with modulation of insulin-like growth factor transport, lysosomal machinery and extracellular matrix receptor interactions
    Liting Deng, Paul A. Haynes, Yunqi Wu, Ardeshir Amirkhani, Karthik Shantharam Kamath, Jemma X. Wu, Kanishka Pushpitha, Veer Gupta, Stuart Graham, Vivek K. Gupta, Mehdi Mirzaei
    2020, 15 (11):  2131-2142.  doi: 10.4103/1673-5374.282261
    Abstract ( 157 )   PDF (3600KB) ( 194 )   Save
    Extracellular deposits of the amyloid-beta peptide (Aβ) are known as the main pathological hallmark of Alzheimer’s disease. In Alzheimer’s disease, neurons are injured and die throughout the brain, a process in which Aβ neurotoxicity is considered to play an important role. However, the molecular mechanisms underlying Aβ toxicity that lead to neurodegeneration are not clearly established. Here we have elucidated the molecular pathways and networks which are impacted by Aβ in neurons using SH-SY5Y human neu- roblastoma cells as a model. These cells were treated with Aβ 1–42 peptides to study changes in biochemical networks using tandem mass tag labeled quantitative proteomic technique followed by computational anal- ysis of the data. The molecular impacts of Aβ on cells were evident in a time- and dose-dependent manner, albeit the duration of treatment induced greater differential changes in cellular proteome compared to the effects of concentration. Aβ induced early changes in proteins associated with lysosomes, collagen chain trimerization and extracellular matrix receptor interaction, complement and coagulation cascade, oxida- tive stress induced senescence, ribosome biogenesis, regulation of insulin-like growth factor transport and uptake by insulin-like growth factor-binding protein. These novel findings provide molecular insights on the effects of Aβ on neurons, with implications for better understanding the impacts of Aβ on early neuro- degeneration in Alzheimer’s disease pathology.
    Related Articles | Metrics
    Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson’s disease: significance of SIRT3-mediated FOXO3 deacetylation
    Shuo Zhang, Yan Ma, Juan Feng
    2020, 15 (11):  2143-2153.  doi: 10.4103/1673-5374.282264
    Abstract ( 237 )   PDF (3580KB) ( 218 )   Save
    Trans-(-)-ε-viniferin (ε-viniferin) has antioxidative and anti-inflammatory effects. It also has neuroprotective effects in Huntington’s disease by activating the SIRT3/LKB1/AMPK signaling pathway; however, it remains unknown whether ε-viniferin also has a neuroprotective role in Parkinson’s disease. A Parkinson’s disease cell model was induced by exposing SH-SY5Y cells to 3.0 μM rotenone for 24 hours, and cells were then treated with 1.0 μM ε-viniferin for 24 hours. Treatment with ε-viniferin upregulated SIRT3 expression, which promoted FOXO3 deacetylation and nuclear localization. ε-Viniferin also increased ATP production and decreased reactive oxygen species production. Furthermore, ε-viniferin treatment alleviated rotenone-induced mitochondrial depolarization and reduced cell apoptosis, and restored the expression of mitochondrial homeostasis-related proteins. However, when cells were transfected with SIRT3 or FOXO3 shRNA prior to rotenone and ε-viniferin treatment, these changes were reversed. The results from the present study indicate that ε-viniferin enhances SIRT3-mediated FOXO3 deacetylation, reduces oxidative stress, and maintains mitochondrial homeostasis, thus inhibiting rotenone-in- duced cell apoptosis. ε-Viniferin may therefore be a promising treatment strategy for Parkinson’s disease.
    Related Articles | Metrics
    Knocking down TRPM2 expression reduces cell injury and NLRP3 inflammasome activation in PC12 cells subjected to oxygen-glucose deprivation
    Tao Pan, Qiu-Jiao Zhu, Li-Xiao Xu, Xin Ding, Jian-Qin Li, Bin Sun, Jun Hua, Xing Feng
    2020, 15 (11):  2154-2161.  doi: 10.4103/1673-5374.282271
    Abstract ( 166 )   PDF (1523KB) ( 233 )   Save
    Transient receptor potential melastatin 2 (TRPM2) is an important ion channel that represents a potential target for treating injury caused by cerebral ischemia. However, it is unclear whether reducing TRPM2 expression can help repair cerebral injury, and if so what the mech- anism underlying this process involves. This study investigated the protective effect of reducing TRPM2 expression on pheochromocytoma (PC12) cells injured by oxygen-glucose deprivation (OGD). PC12 cells were transfected with plasmid encoding TRPM2 shRNAS, then subjected to OGD by incubation in glucose-free medium under hypoxic conditions for 8 hours, after which the cells were allowed to reox- ygenate for 24 hours. Apoptotic cells, mitochondrial membrane potentials, reactive oxygen species levels, and cellular calcium levels were detected using flow cytometry. The relative expression of C-X-C motif chemokine ligand 2 (CXCL2), NACHT, LRR, and PYD domain– containing protein 3 (NALP3), and caspase-1 were detected using fluorescence-based quantitative reverse transcription-polymerase chain reaction and western blotting. The rates of apoptosis, mitochondrial membrane potentials, reactive oxygen species levels, and cellular cal- cium levels in the TRPM2-shRNA + OGD group were lower than those observed in the OGD group. Taken together, these results suggest that TRPM2 knockdown reduces OGD-induced neuronal injury, potentially by inhibiting apoptosis and reducing oxidative stress levels, mitochondrial membrane potentials, intracellular calcium concentrations, and NLRP3 inflammasome activation.
    Related Articles | Metrics
    Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
    Ju-Young Oh, Tae-Yeon Hwang, Jae-Hwan Jang, Ji-Yeun Park, Yeonhee Ryu, HyeJung Lee, Hi-Joon Park
    2020, 15 (11):  2162-2168.  doi: 10.4103/1673-5374.282260
    Abstract ( 287 )   PDF (1384KB) ( 173 )   Save
    Despite numerous efforts to overcome neuropathic pain, various pharmacological drugs often fail to meet the needs and have many side effects. Muscovite is an aluminosilicate mineral that has been reported to have an anti-inflammatory effect, but the efficacy of muscovite for neuropathic pain has not been investi- gated. Here, we assessed whether muscovite nanoparticles can reduce the symptoms of pain by controlling the inflammatory process observed in neuropathic pain. The analgesic effects of muscovite nanoparticles were explored using partial sciatic nerve ligation model of neuropathic pain, in which one-third to one- half of the nerve trifurcation of the sciatic nerve was tightly tied to the dorsal side. Muscovite nanoparticles (4 mg/100 μL) was given intramuscularly to evaluate its effects on neuropathic pain (3 days per week for 4 weeks). The results showed that the muscovite nanoparticle injections significantly alleviated partial sci- atic nerve ligation-induced mechanical and cold allodynia. In the spinal cord, the muscovite nanoparticle injections exhibited inhibitory effects on astrocyte and microglia activation and reduced the expression of pro-inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α, interleiukin-6 and monocyte chemoattractant protein-1, which were upregulated in the partial sciatic nerve ligation model. Moreover, the muscovite nanoparticle injections resulted in a decrease in activating transcription factor 3, a neuronal injury marker, in the sciatic nerve. These results suggest that the analgesic effects of muscovite nanoparticle on partial sciatic nerve ligation-induced neuropathic pain may result from inhibiting activation of astro- cytes and microglia as well as pro-inflammatory cytokines. We propose that muscovite nanoparticle is a potential anti-nociceptive candidate for neuropathic pain. All experimental protocols in this study were approved by the Institutional Animal Ethics Committee (IACUC) at Dongguk University, South Korea (ap- proval No. 2017-022-1) on September 28, 2017.
    Related Articles | Metrics